Related Experiment Videos

Surfactant and surfactant inhibitors in meconium aspiration syndrome

P A Dargaville1, M South, P N McDougall

  • 1Department of Neonatology and University Department of Paediatrics, Royal Children's Hospital, Melbourne, Australia.

The Journal of Pediatrics
|January 10, 2001
PubMed

Insights

Meconium aspiration syndrome (MAS) in infants involves lung injury, not just surfactant issues. Elevated protein and albumin in lung lavage fluid indicate toxic pneumonitis with damaged lung epithelium.

Area of Science:

  • Neonatal Medicine
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Meconium aspiration syndrome (MAS) is a significant cause of respiratory distress in newborns.
  • The pathophysiology of MAS involves lung injury beyond simple surfactant deficiency.

Purpose of the Study:

  • To investigate surfactant indices and protein markers in the lung lavage fluid of infants with MAS.
  • To differentiate the role of surfactant dysfunction versus lung injury in MAS.

Main Methods:

  • Analysis of lung lavage fluid from 8 infants with MAS undergoing mechanical ventilation and 11 healthy controls.
  • Measurement of surfactant phospholipid, surfactant protein A, total protein, albumin, and membrane-derived phospholipid concentrations.

Main Results:

  • No significant differences in surfactant phospholipid or surfactant protein A between MAS infants and controls.
  • Elevated concentrations of total protein, albumin, and membrane-derived phospholipid in MAS infants.
  • All MAS infants exhibited hemorrhagic pulmonary edema.

Conclusions:

  • MAS is characterized by toxic pneumonitis with significant epithelial disruption.
  • Proteinaceous exudation and lung edema are key features of MAS, not primarily surfactant deficiency.

Related Concept Videos